Diagnostics to
Enhance Your Everyday
WHO WE ARE
OHC is fierce about responding rapidly to emerging diagnostic needs with innovations for testing in all settings, offering a full range of solutions from rapid at-home testing to point-of-care and lab based molecular systems. We are proud of our relentless focus on quality, service, and R&D responsiveness.
​
OHC has been a leader in the in vitro diagnostic (IVD) industry since our founding in 1996. We strive towards ever expanding a robust array of medical devices for biochemical, immunological, and molecular diagnostics. Today, we export diagnostic sensors, IVD tests, and immunoassay devices to more than 110 countries around the world. With the combination of innovative technology and diagnostics, our mission is to develop the right test platform to produce the right solution.
WHAT WE DO
Molecular Diagnostics
Broad Portfolio of Single-Target
and Multi-Target Infectious Disease Genefinder™ PCR Tests Compatible
​
-
15+ tests
-
EX-Mate 32 Plus
(extraction equipment) -
Custom design and
manufacturing
Immunological Diagnostics
Global Expert in Design, Manufacturing, and Distribution of Immunodiagnostics Platforms and Assays
​
-
COVID-19/Influenza A&B
-
SelexON (Human & Vetrinary)
-
Custom design
-
Custom labeling
Biological Diagnostics
Comprehensive Solutions to Measure Substances Produced by Various Metabolism in the Body
​
-
Blood Glucose Meter
-
Glycopoietic Pigment Measuring Instrument
-
Cholesterol Meter
-
Liver Disease Detector
WHY OHC?
Global Reach
Millions of Tests Performed In 100+ Countries
Broad Portfolio Of Single Target And Multi-Target Infectious Disease Genefinder™ PCR Tests Compatible
​
-
15+ tests
-
EX-Mate 32 Plus
(extraction equipment) -
Custom design and manufacturing
Manufacturing Quality
​
Registrations for:
-
01ISO 90
-
ISO 13485
-
KGMP
-
MDSAP
Broad IP Portfolio
​
189 Patents Issued Worldwide
Leaders In COVID-19
Testing
The OHC COVID-19 Antigen Self Test is a lateral flow assay intended for the qualitative detection of COVID-19 in nasal swab samples collected from individuals within 7 days of the onset of symptoms or infected individuals without symptoms. LEARN MORE >
​
Note: For in vitro diagnostic use only. For use under FDA EUA only.
Rapid Self Testing
Anytime, Anywhere
Quality Manufacturing
at a Significant Scale
Trusted And Tested
FDA Approved
NIH RADx Graduate
NIH ITAP Graduate
Comprehensive
Detects Known
SARS-Cov-2 Clinical Variants
Leading COVID-19 Testing
The OHC COVID-19/Flu Antigen Test (QuickFinder) is a lateral flow assay intended for the qualitative detection of COVID-19 and Influenza A and B in nasal swab samples collected from individuals within 5 days of symptom onset or from asymptomatic individuals. LEARN MORE >
​
Note: For in vitro diagnostic use only. For use under FDA EUA only.
Rapid Self Testing
Anytime, Anywhere
Quality Manufacturing
at a Significant Scale
Trusted And Tested
FDA Approved
NIH RADx Graduate
NIH ITAP Graduate
Comprehensive
Detects known SARS-CoV-2 clinical variants and Influenza A/B
Robust. Single-Tube.
Cost-Effective.
Leverage your existing real-time PCR instruments to seamlessly integrate the reliable and affordable GeneFinder
COVID-19 Plus RealAmp test into your
lab workflow.
​
Note: For in vitro diagnostic use only. For use under FDA EUA only.
Responsive To Emerging Health Challenges
Prepare Your Lab For Monkeypox With GeneFinder™
OHC rapidly developed a research use only GeneFinder™ Monkeypox Virus (MPXV) RealAmp Kit in response to the growing threat of a monkeypox virus epidemic. This single-tube PCR test is compatible with common real-time PCR platforms for the qualitative detection of non-variola orthopoxvirus species, of which Monkeypox virus (MPXV) is a member.
​
Note: For in vitro diagnostic use only. For use under FDA EUA only.
